World's Best Scientists 2026 revealed!
Mårten Segelmark

Mårten Segelmark

D-Index & Metrics

Microbiology

D-Index
56
Citations
15579
World Ranking
3664
National Ranking
72

Overview

Mårten Segelmark is affiliated with Lund University in Sweden and has a significant body of research primarily focused on medicine, with a strong emphasis on nephrology, pulmonary and respiratory medicine, and rheumatology. Their work intersects several subfields, including physiology and genetics.

The scientist has contributed extensively to topics related to vasculitis and associated conditions, renal diseases and glomerulopathies, as well as dialysis and renal disease management. Additional areas of study include chronic kidney disease and diabetes, coagulation processes, bradykinin, polyphosphates, and angioedema, along with sarcoidosis, beryllium toxicity research, and otitis media and relapsing polychondritis.

Notable recent publications by Mårten Segelmark include:

  • EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update, 2023, Annals of the Rheumatic Diseases
  • CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden, 2021, American Journal of Kidney Diseases
  • 2020 international consensus on ANCA testing beyond systemic vasculitis, 2020, Autoimmunity Reviews
  • Rituximab in Membranous Nephropathy, 2021, Kidney International Reports
  • Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?, 2020, Autoimmunity Reviews

The scientist frequently publishes in the following venues:

  • Nephrology Dialysis Transplantation
  • Lara D. Veeken
  • Kidney International Reports
  • Journal of the American Society of Nephrology
  • Clinical Kidney Journal

Mårten Segelmark has collaborated with several researchers with notable frequency, including:

  • Aladdin J Mohammad
  • Annette Bruchfeld
  • Andreas Kronbichler
  • David Jayne
  • Marie Evans

Best Publications

  • Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

    Rachel B. Jones;Jan Willem Cohen Tervaert;Thomas Hauser;Raashid Luqmani

  • Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

    Richard Watts;Suzanne Lane;Thomas Hanslik;Thomas Hauser

  • EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

    M. Yates;M. Yates;R. A. Watts;I. M. Bajema;M. C. Cid

  • Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle

  • Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

    David R W Jayne;Annette N Bruchfeld;Lorraine Harper;Matthias Schaier

  • Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

    Aladdin J Mohammad;Lennart T H Jacobsson;Kerstin W A Westman;Gunnar Sturfelt

  • Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

    Josef Coresh;Hiddo J L Heerspink;Yingying Sang;Kunihiro Matsushita

  • Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden

    Aladdin Mohammad;L. T. H. Jacobsson;A. D. Mahr;Gunnar Sturfelt

  • Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

    Rachel B. Jones;Shunsuke Furuta;Jan Willem Cohen Tervaert;Thomas Hauser

  • Circulating microRNA expression profiles associated with systemic lupus erythematosus

    Anting Liu Carlsen;Aaron J Schetter;Christoffer Nielsen;Christian Lood

  • Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

    Stephen P. McAdoo;Anisha Tanna;Zdenka Hrušková;Lisa Holm

  • Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

    Alexandre Karras;Christian Pagnoux;Marion Haubitz;Kirsten de Groot

  • EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

    Neil Basu;Richard Watts;Ingeborg Bajema;Bo Baslund

  • Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.

    Daniel Söderberg;Mårten Segelmark

  • CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden

    Oskar Swartling;Helena Rydell;Maria Stendahl;Mårten Segelmark

  • The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis

    Mårten Segelmark;Abdul Nasser Elzouki;Jörgen Wieslander;Sten Eriksson

  • Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.

    Patrick H. Nachman;Mårten Segelmark;Kerstin Westman;Susan L. Hogan

  • Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?

    Mårten Segelmark;B Persson;Thomas Hellmark;Jörgen Wieslander

  • Diagnosis and classification of Goodpasture's disease (anti-GBM).

    Thomas Hellmark;Mårten Segelmark

  • Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants

    Jia Jin Yang;Gloria A. Preston;William F. Pendergraft;Mårten Segelmark

  • Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals

    Zhao Cui;Ming-hui Zhao;Mårten Segelmark;Thomas Hellmark

  • Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils

    Susanne Bauer;Mohamed Abdgawad;Lena Gunnarsson;Mårten Segelmark

Frequent Co-Authors

David Jayne
David Jayne University of Cambridge
Jörgen Wieslander
Jörgen Wieslander Lund University
Per Eriksson
Per Eriksson Karolinska University Hospital
Alan D. Salama
Alan D. Salama University College London
Richard A. Watts
Richard A. Watts University of East Anglia
Charles D. Pusey
Charles D. Pusey Imperial College London
Raashid Luqmani
Raashid Luqmani University of Oxford
Caroline O. S. Savage
Caroline O. S. Savage Academy of Medical Sciences
Jan Willem Cohen Tervaert
Jan Willem Cohen Tervaert University of Alberta
Diana Karpman
Diana Karpman Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths beyond the laboratory. For those interested in the intersection of health and patient care, becoming a functional medicine nurse practitioner is an emerging option. Exploring functional medicine np programs can provide the specialized training necessary for this role.

On the administrative side, careers in medical coding and health information are growing rapidly. Pursuing certification, such as a certified professional coder (cpc), can lead to stable and well-compensated positions within healthcare facilities.

For microbiology graduates interested in data management and healthcare systems, health information management offers substantive opportunities. Understanding health information management salary expectations helps gauge the career's financial benefits and growth potential.

To build a strong foundation, consider enrolling in one of the best online health information management degree cahiim accredited programs. These accredited degrees equip students with the credentials necessary to excel in the health information field.

Best Scientists Citing Mårten Segelmark

Trending Scientists

Recently Published Articles